Levels of N-acylethanolamines in O,O,S-trimethylphosphorothioate (OOS-TMP)-treated C57BL/6J mice and potential anti-obesity, anti-diabetic effects of OOS-TMP in hyperphagia and hyperglycemia mouse models

Pharmacology Biochemistry and Behavior

Volumn 92, Issue 1, 2009, Pages 1-5

  Huang, Linfang ^a,b   Toyoshima, Megumi ^b   Asakawa, Akihiro ^b   Inoue, Kayoko ^b   Harada, Kouji ^b   Kinoshita, Tomomi ^c   Chen, Shilin ^a   Koizumi, Akio ^b  

^a INSTITUTE OF MEDICINAL PLANT DEVELOPMENT   (China)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Akita mice; Anorexia; Anti diabetic; Anti obesity; db db mice; GC MS; N acylethanolamines; O,O,S trimethylphosphorothioate

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANTIDIABETIC AGENT; ANTIOBESITY AGENT; ETHANOLAMINE DERIVATIVE; GLUCOSE; N ACYLETHANOLAMINE; N STEAROYLETHANOLAMINE; PHOSPHOROTHIOIC ACID O,O,S TRIMETHYL ESTER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANOREXIA; ARTICLE; C57BL 6 MOUSE; DOWN REGULATION; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPERPHAGIA; HYPOPHAGIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPECIES COMPARISON; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; UPREGULATION;

ANIMALS; ANTI-OBESITY AGENTS; APPETITE DEPRESSANTS; BLOOD GLUCOSE; EATING; ETHANOLAMINES; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HYPERGLYCEMIA; HYPERPHAGIA; HYPOGLYCEMIC AGENTS; INJECTIONS, INTRAVENTRICULAR; INSECTICIDES; INTESTINES; MALE; MICE; MICE, INBRED C57BL; OBESITY; THIOPHOSPHORIC ACID ESTERS; WEIGHT GAIN;

MUS;

EID: 58849095727     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2008.10.003     Document Type: Article

References (36)

1. Aldridge W.N., Miles J.W., Mount D.L., and Verschoyle R.D. The toxicological properties of impurities in malathion. Arch Toxicol 42 (1979) 95-100
2. Aldridge W.N., Dinsdale E.D., Nemery B., and Verschyole R.D. Some aspects of the toxicity of trimethyl and triethyl phosphorothioates. Fundam Appl Toxicol 5 (1985) s47-s60
3. Asakawa A., Inui A., Kaga T., Yuzuriha H., Nagata T., Fujimiya M., et al. A role of ghrelin in neuroendocrine and behavioral responses to stress in mice. Neuroendocrinology 74 (2001) 143-147
4. Cota D., Marsicano G., Tschöp M., Grübler Y., Flachskamm C., Schubert M., et al. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 112 (2003) 423-431
5. Darmani N.A. The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by Δ9-tetrahydrocannabinol and other cannabinoids. J Pharmacol Exp Ther 1 (2002) 34-42
6. Engeli S., Böhnke J., Feldpausch M., Gorzelniak K., Janke J., Bátkai S., et al. Activation of the peripheral endocannabinoid system in human obesity. Diabetic 54 (2005) 2838-2843
7. Felder C.C., Nielsen A., Briley E.M., Palkovits M., Priller J., Axelrod J., et al. Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. FEBS Lett 393 (1996) 231-235
8. Gandy J., and Imamura T. Cellular responses to O,O,S-trimethyl phosphorothioate-induced pulmonary injury in rats. Toxicol Appl Pharmacol 80 (1985) 51-57
9. Giuffrida A., and Piomelli D. Isotope dilution GC/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma. FEBS Lett 422 (1998) 373-376
10. Hansen H.S., Moesgaard B., Petersen G., and Hansen H.H. Putative neuroprotective actions of N-acyl-ethanolamines. Pharmacol Ther 95 (2002) 119-126
11. Hasegawa J., and Koizumi A. Structure and pulmonary toxicity relationship on O,O-dimethyl S-alkyl phosphorothioate esters. Pharmacol Toxicol 66 (1990) 367-372
12. Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., et al. International Union of Pharmacology classification of cannabinoid receptors. Pharmacol Rev 54 (2002) 161-202
13. Huang L.F., Toyoshima M., Asakawa A., Inoue K., Harada K., Kinoshita T., et al. Roles of neuropeptides in O,O,S-trimethylphosphorothioate (OOS-TMP)-induced anorexia in mice. Biochem Biophys Res Commun 362 (2007) 177-182
14. Hummel K.P., Dickie M.M., and Coleman D.L. Diabetes, a new mutation in the mouse. Science 153 (1966) 1127-1128
15. Imamura T., Gandy J., and Fukuto T.R. Selective inhibition of rat pulmonary monooxygenase by O,O,S-trimethyl phosphorothioate treatment. Biochem Pharmacol 32 (1983) 3191-3195
16. Imamura T., Hasegawa L., Gandy J., and Fukuto T.R. Effect of drug metabolism inducer and inhibitor on O,O,S-trimethyl phosphorothioate induced delayed toxicity in rats. Chem-Biol Interact 45 (1983) 53-64
17. Kirkham T.C., Williams C.M., Fezza F., and Marzo V.D. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting,feeding and satiation:stimulation of eating by 2-arachidonoylglycerol. Br J Pharmacol 136 (2002) 550-557
18. Koizumi A., Montalbo M., Nguyen Q., Hasegawa L., and Imamura T. Neonatal death and lung injury in rats caused by intrauterine exposure to O,O,S-trimethylphosphorothioate. Arch Toxicol 61 (1988) 378-386
19. Mechoulam R., Ben-Shabat S., Hanus L., Ligumsky M., Kaminski N.E., Schatz A.R., et al. Identification of an endogenous 2-monoglyceride,present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50 (1995) 83-90
20. Ohtaka K., Hamade N., Yamazaki Y., Suzuki M., and Koizumi A. A direct involvement of the central nervous system in hypophagia and inhibition of respiratory rate in rats after treatment with O,O,S-trimethyl phosphorothioate. Arch Toxicol 69 (1995) 559-564
21. Onaivi E.S., Leonard C.M., Ishiguro H., Zhang P.W., Lin Z.C., Akinshola B.E., and Uhl G.R. Endocannabinoids and cannabinoid receptor genetics. Prog Neurobiol 66 (2002) 307-344
22. Pacher P., Batkai S., and Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58 (2006) 389-462
23. Pagotto U., and Pasquali R. Fighting obesity and associated risk factors by antagonising cannabinoid type 1 receptors. The Lancet 365 (2005) 1363-1364
24. Schmid H.H.O., Schmid P.C., and Natarajan V. N-acylated glycerophospholipids and their derivatives. Prog Lipid Res 29 (1990) 1-43
25. Schmid P.C., Krebsbach R.J., Perry S.R., Dettmer T.M., Maasson J.L., and Schmid H.H. Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain. FEBS Lett 375 1-2 (1995) 117-120
26. Schmid H.H.O., Schmid P.C., and Berdyshev E.V. Cell signaling by endocannabinoids and their congeners: questions of selectivity and other challenges. Chem Phys Lipids 121 (2002) 111-134
27. Schwartz M.W., Woods S.C., Porte D.J., Seeley R.J., and Baskin D.G. Central nervous system control of food intake. Nature 404 (2000) 661-671
28. Shao J., Yamashita H., Qiao L., and Friedman J.E. Decreased Akt kinase activity and insulin resistance in C57BL/KsJ-Leprdb/db mice. J Endocrinol 167 (2000) 107-115
29. Sugiura T., Kondo S., Sukagawa A., Nakane S., Shinoda A., Itoh K., et al. 2-Arachidonoylglycerol:apossible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215 (1995) 89-97
30. Terrazzino S., Berto F., Dalle Carbonare M., Fabris M., Guiotto A., Bernardini D., et al. Stearoylethanolamide exerts anorexic effects in mice via down-regulation of liver stearoyl-coenzyme A desaturase-1 mRNA expression. FASEB 18 (2004) 1580-1582
31. Toyoshima M., Asakawa A., Fujimiya M., Inoue K., Inoue S., Kinboshi M., et al. Dimorphic gene expression patterns of anorexigenic and orexigenic peptides in hypothalamus account male and female hyperphagia in Akita type 1 diabetic mice. Biochem Biophys Res Commun 19 (2007) 703-708
32. Umetsu N., Grose F.H., Allahyari R., Abu-El-Haj S., and Fukuto T.R. Effect of impurities on the mammalian toxicity of technical malathion and acephate. J Agric Food Chem 25 (1977) 946-953
33. Verschoyle R.D., and Cabral J.R.P. Investigation of the acute toxicity of some trimethyl and triethyl phosphorothioates with particular reference to those causing lung damage. Arch Toxicol 51 (1982) 221-231
34. Wang J., Takeuchi T., Tanaka S., Kubo S.K., Kayo T., Lu D., et al. A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse. J Clin Invest 103 (1999) 27-37
35. Yang H.Y.T., and Karoum F. GC/MS analysis of anandamide and quantification of N-arachidonoylphosphatidyl ethanolamides in various brain regions, spinal cord, testis, and spleen of the rat. J Neurochem 72 5 (1999) 1959-1968
36. Yoshioka M., Kayo T., Ikeda T., and Koizumi A. A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes 46 (1997) 887-894